On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib

Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!!

Read our latest press releases here:

• Progeria Research Foundation Announces Collaboration and Supply Agreement with Eiger BioPharmaceuticals 
• Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria

زوي او کارلي بوسټن ته د دوی وروستي کلینیکي ازموینې لیدنې پرمهال د لونافارنیب درملنه ترلاسه کوي.